SCHEMBL2950670

SCHEMBL2950670

CC1(C)C(=O)C=C[C@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2954822 1.00 — —
SCHEMBL13507259 0.72 — —
SCHEMBL13507742 0.65 — —
SCHEMBL16431206 0.65 — —
SCHEMBL28124541 0.65 — —
SCHEMBL15716844 0.63 PDK2 (0.34) —
SCHEMBL7257768 0.60 — —
SCHEMBL19326952 0.59 — —
SCHEMBL732762 0.59 — —
SCHEMBL11451525 0.59 CYP3A4 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-60132975-A — — None — — JP disclosed
US-7759399-B2 Pharmaceutical compositions CRAWFORD HEALTHCARE HOLDINGS LIMITED (GB) 2010-07-20 — — US disclosed
US-7759399-B2 Pharmaceutical compositions CRAWFORD HEALTHCARE HOLDINGS LIMITED (GB) 2010-07-20 — — US disclosed
US-7759399-B2 Pharmaceutical compositions CRAWFORD HEALTHCARE HOLDINGS LIMITED (GB) 2010-07-20 — — US disclosed
US-20060252839-A1 Pharmaceutical compositions BIOGEM S.C.A.R.L. (IT) 2006-11-09 — — US disclosed
EP-1487789-A2 IMPROVEMENTS IN PHARMACEUTICAL COMPOSITIONS Charterhouse Therapeutics Ltd. (GB) 2004-12-22 — — EP disclosed
WO-2003082813-A2 IMPROVEMENTS IN PHARMACEUTICAL COMPOSITIONS CHARTERHOUSE THERAPEUTICS LIMITED (GB) 2003-10-09 — — WO disclosed
JP-S60132975-A CYCLOPENTENONE ETHER DERIVATIVE AND ITS PRODUCTION SUMITOMO CHEM CO LTD 1985-07-16 — — JP disclosed
Send feedback